Patents by Inventor Umit Cifter

Umit Cifter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110294885
    Abstract: An orally-administrable controlled-release formulation, including pregabalin or a pharmaceutically acceptable salt of pregabalin and polycarbophil, as a controlled-release agent.
    Type: Application
    Filed: May 25, 2011
    Publication date: December 1, 2011
    Applicant: Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Aylin Yildirim
  • Publication number: 20110294886
    Abstract: A controlled-release tablet formulation which gels in the stomach, including pregabalin or a pharmaceutically acceptable salt thereof, and a complex of sodium alginate and calcium chloride, or calcium alginate, or a properly-proportioned mixture thereof as a controlled-release agent.
    Type: Application
    Filed: May 25, 2011
    Publication date: December 1, 2011
    Applicant: Sanovell llac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin
  • Publication number: 20110294887
    Abstract: A controlled-release oral solution formulation, which gels in the stomach, includes pregabalin or a pharmaceutically acceptable salt of pregabalin and a gelling agent.
    Type: Application
    Filed: May 25, 2011
    Publication date: December 1, 2011
    Applicant: Sanovell Illac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin
  • Publication number: 20110288138
    Abstract: Silicon dioxide free orally disintegrating tablet formulations of zolmitriptan or a pharmaceutically acceptable salt thereof having magnesium carbonate heavy and sodium stearyl fumarate with one or more pharmaceutically acceptable excipients and a process for preparing such a formulation and its use in the treatment of migraines.
    Type: Application
    Filed: May 20, 2011
    Publication date: November 24, 2011
    Applicant: Sanovel llac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Gulay Yelken
  • Publication number: 20110274753
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Publication number: 20110274751
    Abstract: A multilayered solid oral pharmaceutical formulation of trimetazidine or a pharmaceutically acceptable salt or polymorph of trimetazidine wherein one layer of said formulation provides controlled release, while the other layer provides immediate release.
    Type: Application
    Filed: May 3, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Aylin Yildirim, Levent Oner
  • Publication number: 20110274754
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel llac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Publication number: 20110274752
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel llac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Publication number: 20110268797
    Abstract: An oral pharmaceutical formulation of aliskiren, or a pharmaceutically acceptable salt or polymorph thereof, having at least two coating layers.
    Type: Application
    Filed: April 29, 2011
    Publication date: November 3, 2011
    Applicant: Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Gulay Yelken
  • Publication number: 20110257159
    Abstract: Silicon dioxide free orally disintegrating tablet formulations of mirtazapine or a pharmaceutically acceptable salt thereof having crospovidone and sodium stearyl fumarate and one or more pharmaceutically acceptable excipients and a process for preparing such a formulation.
    Type: Application
    Filed: April 15, 2011
    Publication date: October 20, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp, Gulay Yelken
  • Publication number: 20110236473
    Abstract: An oral pharmaceutical formulation, made up of croscarmellose sodium and internal granules including a pharmaceutically acceptable salt or polymorph of aliskiren and stearic acid.
    Type: Application
    Filed: March 23, 2011
    Publication date: September 29, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Gulay Yelken
  • Publication number: 20110223245
    Abstract: A controlled-release pharmaceutical formulation, comprising pramipexole or a pharmaceutically acceptable salt of pramipexole, colloidal silicone dioxide, and glyceryl behenate.
    Type: Application
    Filed: March 10, 2011
    Publication date: September 15, 2011
    Applicant: Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp, Gulay Yelken, Levent Oner
  • Publication number: 20110071098
    Abstract: A topical pharmaceutical gel includes flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, thiocolchicoside or a pharmaceutically acceptable salt of thiocolchicoside, and menthol. Pharmaceutical combinations of flurbiprofen, thiocolchicoside, and menthol in the form of topical gels with anti-inflammatory, analgesic, and myorelaxant activities are described.
    Type: Application
    Filed: September 20, 2010
    Publication date: March 24, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Fatih Cakir, Ali Turkyilmaz, Umit Cifter
  • Publication number: 20110053877
    Abstract: A topical pharmaceutical formulation made up of nimesulide or a pharmaceutically acceptable derivative of nimesulide, together with thiocolchicoside or a pharmaceutically acceptable derivative of thiocolchicoside. The present invention more particularly relates to pharmaceutical combinations of nimesulide and thiocolchicoside, in the form of topical gels, ointments, cream, sprays, or lotions with anti-inflammatory, analgesic, and myorelaxant activities.
    Type: Application
    Filed: August 31, 2010
    Publication date: March 3, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Fatih Cakir, Ali Turkyilmaz, Levent Oner, Umit Cifter
  • Publication number: 20100272800
    Abstract: According to the present invention an orally disintegrating olanzapine tablet comprising magnesium stearate and sodium stearyl fumarate and one or more phramaceutically acceptable excipient in which the total weight of magnesium stearate and sodium stearyl fumarate is about 0.1 to 5% by weight of the total tablet and wherein the tablet disintegrates within up to 90 seconds in oral cavity is provided.
    Type: Application
    Filed: April 15, 2010
    Publication date: October 28, 2010
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Ali Turkyilmaz, Tuba Yasar, Yucel Dogu
  • Publication number: 20100234342
    Abstract: This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same.
    Type: Application
    Filed: March 15, 2010
    Publication date: September 16, 2010
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Levent Oner, Ali Turkyilmaz, Ibrahim Murat Uzer, Gaye Ramazanoglu
  • Publication number: 20090175938
    Abstract: This invention is a novel controlled release (CR) flurbiprofen and muscle relaxant combinations for oral administration with anti-inflammatory, analgesic, myorelaxant activity and methods of its manufacture. The pharmaceutical composition of the present invention is administered orally in tablet, multilayer tablet, multicoated tablet and capsule form.
    Type: Application
    Filed: December 24, 2008
    Publication date: July 9, 2009
    Applicant: SANOVEL ILAC SANAYI VE TICARET A.S.
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp
  • Publication number: 20090017116
    Abstract: The present invention relates to an extended release (XL) pharmaceutical tablet composition for oral administration and methods of its manufacture. More particularly, the present invention relates to an extended release gliclazide formulation which does not increase the blood glucose level in human patients.
    Type: Application
    Filed: July 11, 2008
    Publication date: January 15, 2009
    Applicant: SANOVEL ILAC SANAYI VE TICARET A.S.
    Inventors: Umit CIFTER, Ali TURKYILMAZ, Levent ONER
  • Publication number: 20080293789
    Abstract: The present invention relates to a new pharmaceutical formulation in the form of a tablet consisting of valsartan as an active agent, pregelatinized starch, microcrystalline cellulose.
    Type: Application
    Filed: May 23, 2008
    Publication date: November 27, 2008
    Applicant: Sanovell Ilac Sanayi Ve Ticaret A.S.
    Inventors: Umit CIFTER, Ali TURKYILMAZ, Hasan Ali TURP
  • Publication number: 20080279933
    Abstract: This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an ?-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Application
    Filed: May 8, 2008
    Publication date: November 13, 2008
    Applicant: Sanovel Ilac Sanayi Ve Ticaret A.S.
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp